Bullfrog AI Holdings, Inc. Common Stock (BFRG) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Healthcare Information Services secteur d'activité. Le siège social de l'entreprise est situé à Gaithersburg, MD, United States. Le PDG actuel est Vininder Singh.
BFRG a date d'introduction en bourse 2023-02-13, 4 employés à temps plein, cotée sur le NASDAQ Capital Marke, une capitalisation boursière de $9.94M.
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
